Literature DB >> 19147051

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.

Jay S Skyler1, Richard Bergenstal, Robert O Bonow, John Buse, Prakash Deedwania, Edwin A M Gale, Barbara V Howard, M Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S Sherwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19147051     DOI： 10.1016/j.jacc.2008.10.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  113 in total

1.  Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects.

Authors:  Martin Haluzík; Miloš Mráz; Štěpán Svačina
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

Review 2.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 3.  A cardiologist's view of hypoglycemia.

Authors:  Shailesh Nandish; Jamison Wyatt; Rene Oliveros; Adrienne Stevens Zion; Michael Lujan; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

4.  The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects.

Authors:  M Lind; A Odén; M Fahlén; B Eliasson
Journal:  Diabetologia       Date:  2010-03-18       Impact factor: 10.122

Review 5.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

6.  Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers.

Authors:  Jerilyn K Allen; Cheryl R Dennison-Himmelfarb; Sarah L Szanton; Lee Bone; Martha N Hill; David M Levine; Murray West; Amy Barlow; LaPricia Lewis-Boyer; Mary Donnelly-Strozzo; Carol Curtis; Katherine Anderson
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-09-27

Review 7.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

8.  Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction.

Authors:  Tatiane M Murça; Patrícia L Moraes; Carolina A B Capuruço; Sérgio H S Santos; Marcos B Melo; Robson A S Santos; Vinayak Shenoy; Michael J Katovich; Mohan K Raizada; Anderson J Ferreira
Journal:  Regul Pept       Date:  2012-05-14

9.  Gender differences in cardiovascular risk factors in incident diabetes.

Authors:  Emily B Schroeder; Elizabeth A Bayliss; Stacie L Daugherty; John F Steiner
Journal:  Womens Health Issues       Date:  2014 Jan-Feb

10.  Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase.

Authors:  Steven C Rogers; Xiaomin Zhang; Gohar Azhar; Shaoke Luo; Jeanne Y Wei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-04-12       Impact factor: 6.053
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.